289 related articles for article (PubMed ID: 16581078)
1. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
Gable DR; Hurel SJ; Humphries SE
Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
[TBL] [Abstract][Full Text] [Related]
2. [Variants of adiponectin gene as risk factors for the metabolic syndrome].
Szopa M; Malczewska-Malec M; Wybrańska I; Kieć-Wilk B
Przegl Lek; 2009; 66(5):257-62. PubMed ID: 19739584
[TBL] [Abstract][Full Text] [Related]
3. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.
Rabin KR; Kamari Y; Avni I; Grossman E; Sharabi Y
Expert Rev Cardiovasc Ther; 2005 May; 3(3):465-71. PubMed ID: 15889974
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K; Tobe K
J Clin Invest; 2006 Jul; 116(7):1784-92. PubMed ID: 16823476
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
7. Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers.
Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Bouslama A
Metab Syndr Relat Disord; 2011 Dec; 9(6):419-26. PubMed ID: 21870907
[TBL] [Abstract][Full Text] [Related]
8. A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome.
Bueno AC; Sun K; Martins CS; Elias Junior J; Miranda W; Tao C; Foss-Freitas MC; Barbieri MA; Bettiol H; de Castro M; Scherer PE; Antonini SR
J Clin Endocrinol Metab; 2014 Apr; 99(4):E683-93. PubMed ID: 24432991
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin, obesity, and cardiovascular disease.
Fasshauer M; Paschke R; Stumvoll M
Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
[TBL] [Abstract][Full Text] [Related]
10. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin: a key adipocytokine in metabolic syndrome.
Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
14. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
Matsuzawa Y
Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616
[TBL] [Abstract][Full Text] [Related]
15. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.
Menzaghi C; Trischitta V; Doria A
Diabetes; 2007 May; 56(5):1198-209. PubMed ID: 17303804
[TBL] [Abstract][Full Text] [Related]
16. Adipose inflammation, insulin resistance, and cardiovascular disease.
Shah A; Mehta N; Reilly MP
JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin, the missing link in insulin resistance and obesity.
Gil-Campos M; Cañete RR; Gil A
Clin Nutr; 2004 Oct; 23(5):963-74. PubMed ID: 15380884
[TBL] [Abstract][Full Text] [Related]
18. Insulin effect on adipose tissue (AT) adiponectin expression is regulated by the insulin resistance status of the patients.
Hernandez-Morante JJ; Milagro FI; Lujan JA; Martinez JA; Zamora S; Garaulet M
Clin Endocrinol (Oxf); 2008 Sep; 69(3):412-7. PubMed ID: 18208577
[TBL] [Abstract][Full Text] [Related]
19. Relationship between adiponectin, obesity and insulin resistance.
Balsan GA; Vieira JL; Oliveira AM; Portal VL
Rev Assoc Med Bras (1992); 2015; 61(1):72-80. PubMed ID: 25909213
[TBL] [Abstract][Full Text] [Related]
20. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
You T; Yang R; Lyles MF; Gong D; Nicklas BJ
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
